Cargando…
Correction Necessary Regarding CMS Guidance for Coverage of New Multiple-Source Brand Drugs
Autor principal: | DePue, Ronnie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438072/ https://www.ncbi.nlm.nih.gov/pubmed/17407399 http://dx.doi.org/10.18553/jmcp.2007.13.3.290 |
Ejemplares similares
-
Medicare Part D: Selected Issues for Plan Sponsors, Pharmacists, and Beneficiaries in 2008
por: DePue, Ronnie, et al.
Publicado: (2008) -
Pharmacist Intervention in Safe and Effective Conversion of Brand to Generic Drugs
por: Summers, Kent H.
Publicado: (2005) -
Effects of Medicare Part D coverage gap closure on utilization of branded and generic drugs
por: Liu, Judith, et al.
Publicado: (2022) -
More Vigilance on Generic Drugs are Necessary
por: John, Mathew
Publicado: (2020) -
Regarding: COVID-19 vaccination during pregnancy: coverage and safety
por: Nagabhushana, Prerana, et al.
Publicado: (2022)